MDS Virtual Congress 2020 Archives - Page 120 of 149

GAD65 antibody neurologic syndrome presenting with hemiparkinsonism

R. Patel, N. Witek, P. Pinna, M. Afshari (Chicago, IL, USA)
Gait and motion analysis in Progressive Supranuclear Palsy

F. Ali, S. Loushin, K. Josephs, K. Kaufman, J. Whitwell (Rochester, MN, USA)
Gait and turning alterations in idiopathic REM sleep behavioral disorder and early Parkinson’s disease: a cross-sectional study with mobile health technology

A. Pilotto, M. Catania, A. Galbiati, C. Hansen, R. Romijnders, A. Corbani, S. Nocivelli, S. Masciocchi, A. Imarisio, M. Rizzetti, L. Ferini-Strambi, W. Maetzler, A. Padovani (Brescia, Italy)
Gait initiation in patients with Progressive Supranuclear Palsy: a biomechanical and FDG-PET study

M. Todisco, C. Palmisano, G. Marotta, C. Pacchetti, G. Pezzoli, I. Isaias (Würzburg, Germany)
GCH1 variants contribute to risk and earlier age at onset in Parkinson’s disease

Y. Zhao, H. Pan, Q. Sun, Q. Xu, X. Yan, J. Li, B. Tang, J. Guo (Changsha, China)
GCI-induced neurodegeneration and synucleinopathy in non-human primates

M. Teil, S. Dovero, M.L Artocarena, M. Bourdenx, G. Porras, B. Mollenhauer, M.T Herrero, M. Vila, J. Obeso, B. Dehay, E. Bezard (Bordeaux, France)
Gender differenes in cognitive functioning in de novo Parkinson’s disease patients

A. Slomp, S. vd Zee, J. Boertien, J. Spikman, T. van Laar (Groningen, Netherlands)
Gender-related differences in nonmotor symptoms in the context of subthalamic stimulation in Parkinson’s disease

L. Strobel, S. Jost, A. Sauerbier, A. Rizos, K. Ashkan, M. Silverdale, J. Evans, P. Loehrer, F. Rosenkranz, M. Barbe, G. Fink, M. Samuel, K. Ray Chaudhuri, A. Antonini, P. Martinez-Martin, L. Timmermann, V. Visser-Vandewalle, H. Dafsari (Cologne, Germany)
Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population

D. Brito, M. Della Coletta, G. Ferreira, L. Amorim, S. Souza, S. Peixoto, C. Rezende (Manaus, Brazil)
Genetic and environmental prognostics of cognitive trajectories in patients with Parkinson’s disease

S. Jo, K.W Park, S.H Lee, Y.S Hwang, S.J Chung (Seoul, Republic of Korea)
Genetic Profiling of Early Synucleinopathy in Rat Nigrostriatal Dopamine Neurons

J. Patterson, C. Kemp, M. Duffy, J. Howe, C. Russell, A. Stoll, K. Miller, J. Beck, S. Counts, K. Steece-Collier, K. Luk, C. Sortwell (Grand Rapids, MI, USA)
Genetic risk scores and hallucinations in Parkinson’s disease patients

C. Kusters, K. Paul, A. Duarte Folle, A. Keener, J. Bronstein, V. Dobricic, O.B Tysnes, L. Bertram, G. Alves, J. Sinsheimer, C. Lill, J. Maple-Grødem, B. Ritz (Los Angeles, CA, USA)
Genetic testing in pediatric dystonia and influence of clinical factors on diagnostic yield

T. Larsh, H. Fernandez, M. Aldosari (Cleveland, OH, USA)
Genetic, biochemical and clinical findingss in Friedreich’s ataxia patients – relationship with the disease severity

R. Moganty, D. Pathak, A. srivastava, s. Gulati (New Delhi, India)
Genome-wide association studies of progression in Parkinson’s disease

M. Tan, M. Shoai, M. Lawton, S. Kanavou, N. Wood, J. Hardy, Y. Ben-Shlomo, N. Williams, M. Hu, D. Grosset, H. Morris (London, United Kingdom)
Gerstmann-Sträussler-Scheinker disease presenting as a late onset slowly progressive spinocerebellar ataxia: expanding the phenotypic spectrum of genetic prion disease

C. Stephen, J. Chen, B. Appleby, T. Prior, M. Frosch, J. Schmahmann (Boston, MA, USA)
Glucocerebrosidase activity and atypical parkinsonism: a multi-centre exploratory study

R. Alvarez Velasco, P. Giraldo, P. Irun, L. Vela Desojo, L. Lopez Manzanares, J.M Arbelo González, M. Eimil Ortiz, A. Rojo Sebastian, M. Mata Álvarez-Santullano, I. Martínez Torres, J. Garcia-Caldentey, M. Gómez Gutierrez, C. Estévez-Fraga, J.L López Sendón, G. García Ribas, J.C Martínez Castrillo, A. Alonso-Canovas (Madrid, Spain)
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation via Extracellular Vesicle Dysregulation

K. Jewett, R. Thomas, C. Phan, G. Milstein, S. Yu, L. Pallanck, M. Davis (Seattle, WA, USA)
Goalkeeper Game: a new assessment tool for prediction of gait performance under complex condition in people with Parkinson’s disease

R. Stern, M. d'Alencar, Y. Uscapi, M. Gubitoso, A. Roque, A. Helene, M. Piemonte (São Carlos, Brazil)
Gpi Deep Brain Stimulation After Many Years of Subthalamic Nucleus Stimulation: Case Report

Z. Tufekcioglu, T. Karanci, S. Albayrak (Istanbul, Turkey)
GPNMB protein levels in CNS are modulated by PD risk variant rs199347

Y. Seo, M. Diaz Ortiz, D. Weintraub, V. Van Deerlin, J. Trojanowski, A. Chen-Plotkin (Philadelphia, PA, USA)
Graph theory analysis of dopamine D2 receptor network in Parkinson’s disease patients

A. Mihaescu, J. Kim, S. Cho, M. Diez-Cirarda, M. Valli, Y. Koshimori, A. Strafella (Toronto, ON, Canada)
Gut Microbiota in Parkinson’s disease: influences of device-assisted therapies

M. Lubomski, X. Xu, A. Holmes, J. Yang, R. Davis, C. Sue (Sydney, Australia)
Gut Microbiote Distinctive Features and Microbiota-Metabolome Profile in Parkinson’s Disease: Focus on Levodopa and LCIG

M. Melis, V. Oppo, S. Vascellari, M. Fabbri, M. Sarchioto, D. Murgia, M. Zibetti, L. Lopiano, A. Manzin, G. Cossu (Cagliari, Italy)
GWAS on impulse control disorders in Parkinson’s disease

S. Bekadar, F.X Lejeune, F. Danjou, M. Vidailhet, M. Anheim, A. Elbaz, G. Alves, O.B Tysnes, A.H Erga, J. Maple-Grodem, A. Brice, J.C Corvol (Paris, France)